Topics

• ANTITRUST

• Asset Management

• Data, Privacy & Cybersecurity

• Digital Health

• Employee Benefits/ERISA

• Enforcement

• False Claims Act

• FDA REGULATORY

• Health Care

• Intellectual Property

• PRIVATE EQUITY

• TAX

Capital Insights

Analysis

• Podcast: Non-binding Guidance: FDA’s Intended Use Final Rule
  (September 21, 2021)
• Large IRAs and High-Income Retirement Savers Targeted by Amendment to Budget Reconciliation Bill
  (September 20, 2021)
• Representatives Schweikert and DelBene Reintroduce Bipartisan Advancing America’s Interests Act to Curtail Intellectual Property Enforcement at the International Trade Commission
  (September 9, 2021)
• Podcast: Talkin' Trade: The Interplay Between the ITC and the PTAB
  (September 1, 2021)

In The News

• In Bloomberg Law, IP Litigators Analyze Potential Hurdles to U.S. Implementation of a COVID-19-Related IP Rights Waiver 
  (September 16, 2021)
• In National Law Journal and Law360, Matt Rizzolo Examines Next International Trade Commission Administrative Law Judge
  (September 14, 2021)
• In Barron’s and USA Today, Mark Barnes Examines Whether President Biden’s New Vaccine Mandate Can Withstand Legal Challenges
  (September 13, 2021)
• Raffi Teperdjian Co-Authors Artificial Intelligence Article in The George Washington Law Review Arguendo
  (July 30, 2021)